C
Novo Nordisk A/S NVO
$54.18 -$0.1161-0.21% NYSE
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 21.48% 22.67% 24.86% 27.74% 31.76%
Total Other Revenue -- -- -- -- --
Total Revenue 21.48% 22.67% 24.86% 27.74% 31.76%
Cost of Revenue 25.09% 24.10% 23.21% 22.41% 29.06%
Gross Profit 20.83% 22.41% 25.16% 28.74% 32.26%
SG&A Expenses 14.38% 9.26% 9.22% 14.78% 14.91%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -157.84% -682.42% -8.33% 92.85% 50.61%
Total Operating Expenses 18.45% 16.46% 17.85% 21.15% 24.79%
Operating Income 25.00% 30.05% 33.41% 36.22% 40.92%
Income Before Tax 25.18% 16.90% 21.44% 29.07% 38.99%
Income Tax Expenses 29.54% 21.18% 24.76% 37.11% 46.61%
Earnings from Continuing Operations 24.06% 15.82% 20.61% 27.14% 37.16%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 24.06% 15.82% 20.61% 27.14% 37.16%
EBIT 25.00% 30.05% 33.41% 36.22% 40.92%
EBITDA 26.38% 29.01% 31.20% 33.57% 38.99%
EPS Basic 24.60% 16.43% 21.37% 28.09% 38.34%
Normalized Basic EPS 22.46% 25.45% 30.62% 36.58% 47.49%
EPS Diluted 24.77% 16.56% 21.47% 28.16% 38.32%
Normalized Diluted EPS 22.55% 25.55% 30.71% 36.67% 47.57%
Average Basic Shares Outstanding -0.43% -0.54% -0.64% -0.78% -0.90%
Average Diluted Shares Outstanding -0.52% -0.62% -0.72% -0.85% -0.96%
Dividend Per Share 18.93% 19.95% 19.95% 43.18% 43.18%
Payout Ratio -0.04% 0.03% 0.16% 0.10% 0.13%